Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review
Abstract Background Squamous cell carcinoma (SCC) is a relatively common and heterogenous malignancy of different organs, such as the skin, esophagus, and lungs. Although most cases experience good survival with surgical methods, management of advanced types of the disease remains challenging. Sever...
Main Authors: | Amirhossein Tamimi, Atena Tamimi, Fatemeh Sorkheh, Saba Mardekatani Asl, Arezoo Ghafari, Arian Ghannadi Karimi, Gisou Erabi, Hossein Pourmontaseri, Niloofar Deravi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1802 |
Similar Items
-
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
by: Ming Bai, et al.
Published: (2022-03-01) -
Clinical consensus on the treatment of locally advanced squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2023 edition)
by: XU Tingting, HU Chaosu, LI Baosheng
Published: (2023-01-01) -
Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995) -
Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992) -
Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.